🟢 GT Biopharma is trading 2.0% up in pre-market with no clear catalyst identified

GT Biopharma is trading in pre-market at $7.17, up 2.0%, with no clearly established catalyst.

• The shares are above the October 16 close of $7.03.
• No new company-specific announcement dated October 19 was identified; the company’s latest listed press release is dated September 15.
• Market context was mixed: major indices were directionally split, while the biotech sector was reported lower, so broader sentiment does not clearly explain the rise.